References
- Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28(1):573–621. doi: 10.1146/annurev-immunol-030409-101225.
- Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770. doi: 10.1016/S0140-6736(16)32126-2.
- Taylor KD, Yang H, Rotter JI. Inflammatory bowel disease. In: Rimoin D, Pyeritz R, Korf B, editors. Emery and rimoin’s principles and practice of medical genetics. Oxford: Academic Press; 2013. p. 1–3.
- Zhang Q, Sha S, Xu B, et al. Prevalence of colorectal cancer in patients with ulcerative colitis: a retrospective, monocenter study in China. J Cancer Res Ther. 2015;11(4):899–903. doi: 10.4103/0973-1482.143345.
- Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001.
- Dhaneshwar S, Gautam H. Exploring novel Colon-targeting antihistaminic prodrug for colitis. J Physiol Pharmacol. 2012;63(4):327–337.
- Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373(9678):1905–1917. doi: 10.1016/S0140-6736(09)60326-3.
- Panizzi L, Scarpati ML. Constitution of cynarine, the active principle of the artichoke. Nature. 1954;174(4440):1062–1062. doi: 10.1038/1741062a0.
- Marques P, Marto J, Gonçalves L, et al. Cynara scolymus L.: a promising Mediterranean extract for topical anti-aging prevention. Ind Crops Prod. 2017;109:699–706. doi: 10.1016/j.indcrop.2017.09.033.
- Wu C, Chen S, Liu Y, et al. Cynarin suppresses gouty arthritis induced by monosodium urate crystals. Bioengineered. 2022;13(5):11782–11793. doi: 10.1080/21655979.2022.2072055.
- Topal M, Gocer H, Topal F, et al. Antioxidant, antiradical, and anticholinergic properties of cynarin purified from the Illyrian thistle (onopordum illyricum L.). J Enzyme Inhib Med Chem. 2016;31(2):266–275. doi: 10.3109/14756366.2015.1018244.
- Corona A, Fanunza E, Salata C, et al. Cynarin blocks ebola virus replication by counteracting VP35 inhibition of interferon-beta production. Antiviral Res. 2022;198:105251. doi: 10.1016/j.antiviral.2022.105251.
- Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238–249.
- Yan Y, Kolachala V, Dalmasso G, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One. 2009;4(6):e6073. doi: 10.1371/journal.pone.0006073.
- Wallace KL, Zheng LB, Kanazawa Y, et al. Immunopathology of inflammatory bowel disease. World J Gastroenterol. 2014;20(1):6–21. doi: 10.3748/wjg.v20.i1.6.
- Ma B, Whiteford JR, Nourshargh S, et al. Underlying chronic inflammation alters the profile and mechanisms of acute neutrophil recruitment. J Pathol. 2016;240(3):291–303. doi: 10.1002/path.4776.
- Friedrich M, Pohin M, Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50(4):992–1006. doi: 10.1016/j.immuni.2019.03.017.
- Ginhoux F, Schultze JL, Murray PJ, et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol. 2016;17(1):34–40. doi: 10.1038/ni.3324.
- Zhu W, Yu J, Nie Y, et al. Disequilibrium of M1 and M2 macrophages correlates with the development of experimental inflammatory bowel diseases. Immunol Invest. 2014;43(7):638–652. doi: 10.3109/08820139.2014.909456.
- Neurath MF, Pettersson S, Meyer Zum Büschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2(9):998–1004. doi: 10.1038/nm0996-998.
- Mudter J, Weigmann B, Bartsch B, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol. 2005;100(1):64–72. doi: 10.1111/j.1572-0241.2005.40615.x.
- Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54(3):357–363. doi: 10.1136/gut.2004.054353.
- Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313–321.e2. doi: 10.1053/j.gastro.2016.10.020.
- Valatas V, Vakas M, Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol. 2013;305(11):G763–85. doi: 10.1152/ajpgi.00004.2013.
- Hibi T, Ogata H, Sakuraba A. Animal models of inflammatory bowel disease. J Gastroenterol. 2002;37(6):409–417. doi: 10.1007/s005350200060.
- Van Assche G, Manguso F, Zibellini M, et al. Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study. Am J Gastroenterol. 2015;110(5):708–715. doi: 10.1038/ajg.2015.114.
- Bressler B, Marshall JK, Bernstein CN, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology. 2015;148(5):1035–1058.e3. doi: 10.1053/j.gastro.2015.03.001.
- Yuan J, Cheng W, Zhang G, et al. Protective effects of iridoid glycosides on acute colitis via inhibition of the inflammatory response mediated by the STAT3/NF-кB pathway. Int Immunopharmacol. 2020;81:106240. doi: 10.1016/j.intimp.2020.106240.
- Xiao HT, Lin CY, Ho DH, et al. Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis. J Nat Prod. 2013;76(11):2120–2125. doi: 10.1021/np4006772.
- Lutz M, Henríquez C, Escobar M. Chemical composition and antioxidant properties of mature and baby artichokes (Cynara scolymus L.), raw and cooked. J Food Compos Anal. 2011;24(1):49–54. doi: 10.1016/j.jfca.2010.06.001.
- Kabganian R, Carrier D, Rose P, et al. Localization of alkamides, echinacoside and cynarin with echinacea angustifolia. J Herbs, Spices Med Plants. 2003;10(2):73–81. doi: 10.1300/J044v10n02_08.
- Xia N, Pautz A, Wollscheid U, et al. Artichoke, cynarin and cyanidin downregulate the expression of inducible nitric oxide synthase in human coronary smooth muscle cells. Molecules. 2014;19(3):3654–3668. doi: 10.3390/molecules19033654.
- Hakkou Z, Maciuk A, Leblais V, et al. Antihypertensive and vasodilator effects of methanolic extract of inula viscosa: biological evaluation and POM analysis of cynarin, chlorogenic acid as potential hypertensive. Biomed Pharmacother. 2017;93:62–69. doi: 10.1016/j.biopha.2017.06.015.
- Gan HT, Chen YQ, Ouyang Q. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. J Gastroenterol Hepatol. 2005;20(7):1016–1024. doi: 10.1111/j.1440-1746.2005.03862.x.
- Biasi F, Leonarduzzi G, Oteiza PI, et al. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19(14):1711–1747. doi: 10.1089/ars.2012.4530.
- Wéra O, Lancellotti P, Oury C. The dual role of neutrophils in inflammatory bowel diseases. J Clin Med. 2016;5(12):118. doi: 10.3390/jcm5120118.
- Hidalgo-Garcia L, Galvez J, Rodriguez-Cabezas ME, et al. Can a conversation between mesenchymal stromal cells and macrophages solve the crisis in the inflamed intestine? Front Pharmacol. 2018;9:179. doi: 10.3389/fphar.2018.00179.
- Chen J. Pathology. Beijing, China: People’s Medical Publishing House; 2009.
- Xiao HT, Peng J, Hu DD, et al. Qing-dai powder promotes recovery of colitis by inhibiting inflammatory responses of colonic macrophages in dextran sulfate sodium-treated mice. Chin Med. 2015;10(1):29. doi: 10.1186/s13020-015-0061-x.
- Hollenbach E, Neumann M, Vieth M, et al. Inhibition of p38 MAP kinase‐and RICK/NF‐κB‐signaling suppresses inflammatory bowel disease. FASEB J. 2004;18(13):1550–1552. doi: 10.1096/fj.04-1642fje.
- Wang Y, Duan X, Liu X, et al. Rho kinase blockade ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of the NF-κB and IL-6/STAT3 pathways. Inflammation. 2020;43(3):857–867. doi: 10.1007/s10753-019-01171-2.
- Murray PJ, Allen JE, Biswas SK, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi: 10.1016/j.immuni.2014.06.008.
- Isidro RA, Appleyard CB. Colonic macrophage polarization in homeostasis, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol. 2016;311(1):G59–73. doi: 10.1152/ajpgi.00123.2016.
- Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity. 2005;23(4):344–346. doi: 10.1016/j.immuni.2005.10.001.
- Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32(5):593–604. doi: 10.1016/j.immuni.2010.05.007.